3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
14
Genitourinary
10
Sarcoma
9
Head & Neck
6
Thoracic
5
Other solid neoplasm
5
Gastrointestinal
5
Tumor-Agnostic
3
Breast
3
Endocrine
2
Plasma cell
1
Lymphoid
1
Conditions
Pituitary Neoplasms
2
Meningioma
2
Brain Neoplasms
2
Neurilemmoma
1
Nerve Sheath Neoplasms
1
Interventions
lutetium Lu 177 dotatate
30
Magnetic Resonance Spectroscopy
25
pembrolizumab
21
Specimen Handling
18
Nivolumab
17
cabozantinib
14
lenvatinib
12
Everolimus
12
trametinib
11
gallium Ga 68 dotatate
10
dabrafenib
10
Ipilimumab
10
Carboplatin
10
Cisplatin
8
atezolizumab
7
Temozolomide
7
Lutetium-177
7
X-Rays
6
Etoposide
6
Capecitabine
6
surufatinib
5
lanreotide
5
fluorodopa F 18
5
cemiplimab
5
Vemurafenib
5
Paclitaxel
5
Octreotide
5
Lutetium
5
Fluorodeoxyglucose F18
5
Disulfides
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Proton Therapy
×
Endocrine
×
1 year
×
Clear all
NCT04278118
2026-02-17
HiPPI
Emory University
Phase NA
Recruiting
70 enrolled
NCT06831461
2025-09-16
PRIDE
Tata Memorial Centre
Phase NA
Recruiting
156 enrolled